Company to submit sNDA around the end of 1Q 2025 seeking traditional approval of FILSPARI® (sparsentan) for FSGSNet product sales of FILSPARI ...

Company to submit sNDA around the end of 1Q 2025 seeking traditional approval of FILSPARI® (sparsentan) for FSGS Net product sales of FILSPARI totaled $50 million in 4Q 2024; $132 million for full yea ...

Meet mild, reversible acute kidney injury (AKI) -- a sudden loss of kidney function that can go away within 24 hours or, if unchecked, can lead to chronic kidney failure, dialysis or transplant! It ...

S L E is a chronic multisystem autoimmune disease in which cardiovascular disease is a leading cause of mortality, with a ...

What is a kidney scan? A kidney scan is an imaging test that looks at your kidneys. Your health care provider can also see how well blood is flowing in your kidneys. A kidney scan is also called a ...

Travere’s stock price climbed by 14% following the announcement that it will seek an FDA label expansion for Filspari.

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25 If approved, FILSPARI could be the first and only approved medicine indicated ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...

NEW YORK – Maze Therapeutics on Friday said it has treated the first patient in the company's Phase II HORIZON trial, in which it is evaluating MZE829 in patients with kidney disease who carry two ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to taking Ozempic: It may help manage chronic kidney disease (CKD). On January ...

Kingdom Come: Deliverance II doesn't mind making you despair for nearly 20 full hours of play before something clicks. It's truly an incredible achievement for Warhorse Studios, but many won't ...